Octreotide: a novel therapy for refractory sulfonylurea-induced hypoglycemia

Pancreas. 2013 May;42(4):722-3. doi: 10.1097/MPA.0b013e3182769c26.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Blood Glucose / metabolism
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / drug therapy
  • Female
  • Glyburide / adverse effects
  • Humans
  • Hypoglycemia / blood
  • Hypoglycemia / chemically induced
  • Hypoglycemia / drug therapy*
  • Hypoglycemic Agents / adverse effects
  • Metformin / adverse effects
  • Middle Aged
  • Octreotide / therapeutic use*

Substances

  • Blood Glucose
  • Glucovance
  • Hypoglycemic Agents
  • Metformin
  • Octreotide
  • Glyburide